186 related articles for article (PubMed ID: 9920290)
41. Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
Reinhardt A; Liu H; Ma Y; Zhou Y; Zang C; Habbel JP; Possinger K; Eucker J
Anticancer Res; 2018 May; 38(5):2669-2682. PubMed ID: 29715087
[TBL] [Abstract][Full Text] [Related]
42. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
43. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of basic side chain derivatives of Analog II as pure antiestrogens and antitumor agents.
Magarian RA; Avor KS; Overacre LB; Kunchandy J; Paxton TR
Anticancer Drug Des; 1995 Jun; 10(4):311-31. PubMed ID: 7786397
[TBL] [Abstract][Full Text] [Related]
45. MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage.
Wilson JW; Wakeling AE; Morris ID; Hickman JA; Dive C
Int J Cancer; 1995 May; 61(4):502-8. PubMed ID: 7759156
[TBL] [Abstract][Full Text] [Related]
46. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
47. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.
Kanaan YM; Das JR; Bakare O; Enwerem NM; Berhe S; Beyene D; Williams V; Zhou Y; Copeland RL
Anticancer Res; 2009 Jan; 29(1):191-9. PubMed ID: 19331150
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma.
Chaudhary S; Chandrashekar KS; Pai KS; Setty MM; Devkar RA; Reddy ND; Shoja MH
BMC Complement Altern Med; 2015 Mar; 15():50. PubMed ID: 25886964
[TBL] [Abstract][Full Text] [Related]
49. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
50. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells.
Choi EJ; Kim GH
Phytomedicine; 2008 Sep; 15(9):683-90. PubMed ID: 18541420
[TBL] [Abstract][Full Text] [Related]
51. 8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells.
Kim SN; Ahn YH; Kim SG; Park SD; Cho-Chung YS; Hong SH
Int J Cancer; 2001 Jul; 93(1):33-41. PubMed ID: 11391618
[TBL] [Abstract][Full Text] [Related]
52. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.
Singh R; Pervin S; Karimi A; Cederbaum S; Chaudhuri G
Cancer Res; 2000 Jun; 60(12):3305-12. PubMed ID: 10866325
[TBL] [Abstract][Full Text] [Related]
53. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
[TBL] [Abstract][Full Text] [Related]
54. Major triterpenoids in Chinese hawthorn "Crataegus pinnatifida" and their effects on cell proliferation and apoptosis induction in MDA-MB-231 cancer cells.
Wen L; Guo R; You L; Abbasi AM; Li T; Fu X; Liu RH
Food Chem Toxicol; 2017 Feb; 100():149-160. PubMed ID: 28025124
[TBL] [Abstract][Full Text] [Related]
55. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.
Perry RR; Kang Y; Greaves BR
Br J Cancer; 1995 Dec; 72(6):1441-6. PubMed ID: 8519657
[TBL] [Abstract][Full Text] [Related]
56. 2-aryl benzimidazole conjugate induced apoptosis in human breast cancer MCF-7 cells through caspase independent pathway.
Nayak VL; Nagesh N; Ravikumar A; Bagul C; Vishnuvardhan MVPS; Srinivasulu V; Kamal A
Apoptosis; 2017 Jan; 22(1):118-134. PubMed ID: 27770267
[TBL] [Abstract][Full Text] [Related]
57. Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cells.
Grem JL; Politi PM; Berg SL; Benchekroun NM; Patel M; Balis FM; Sinha BK; Dahut W; Allegra CJ
Biochem Pharmacol; 1996 Jun; 51(12):1649-59. PubMed ID: 8687480
[TBL] [Abstract][Full Text] [Related]
58. Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Rabi T; Wang L; Banerjee S
Breast Cancer Res Treat; 2007 Jan; 101(1):27-36. PubMed ID: 17028990
[TBL] [Abstract][Full Text] [Related]
59. 16-Hydroxycleroda-3,13-dien-15,16-olide and N-Methyl-Actinodaphine Potentiate Tamoxifen-Induced Cell Death in Breast Cancer.
Velmurugan BK; Wang PC; Weng CF
Molecules; 2018 Aug; 23(8):. PubMed ID: 30082655
[TBL] [Abstract][Full Text] [Related]
60. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
Patel JB; Mehta J; Belosay A; Sabnis G; Khandelwal A; Brodie AM; Soprano DR; Njar VC
Br J Cancer; 2007 Apr; 96(8):1204-15. PubMed ID: 17387344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
